Table 4. Escherichia coli antibiotic susceptibility between 2004 and 2011 studies according to guidelines used for susceptibility breakpoints.
| Study year | |||
| 2004 (n = 113) | 2011 (n = 188) | ||
| CLSI | EUCAST | EUCAST | |
| Amoxicillin | 75 | 72 | 65 |
| Co-amoxiclav | 100 | 89 | 84 |
| Trimethoprim | 81 | 78 | 77 |
| Co-trimoxazole | 81 | 81 | 78 |
| Norfloxacin | 97 | 95 | 93 |
| Ciprofloxacin | 97 | 96 | 94 |
| Nitrofurantoin | 97 | 97 | 100 |
NOTE. Values are given in percentages.
No significant differences in E. coli susceptiblilities (EUCAST) were observed between 2004 and 2011 study (all P>0.05)